Upcoming Classes

Trichophyton mentagrophytes, genotype VII (TMVII), has been recognized as a fungal infection of concern in the United States since 2024. Transmission has been associated with skin-to-skin contact similar to sexually transmitted infections (STIs) that can also present with a rash. Recognizing TMVII and initiating systemic treatment promptly are key to reducing the transmission of TMVII. The National Network of Prevention Training Centers, in collaboration with the Centers for Disease Control and Prevention and the Minnesota Department of Health, invites you to attend this timely national webinar on TMVII. Learn the basics of recognizing and assessing TMVII, evidence-based recommendations for therapy, and updates on the prevalence and incidence of TMVII in the United States. This webinar will feature expert guidance from leading voices in infectious disease and will include time for questions and answers.

As a result of this activity, the learner will be able to identify at least two key considerations in the recognition, assessment, and management of tricophyton mentagorphytes, genotype VII (TMVII).

Date: 1/29/2026

Time: 9:00-10:15 AM PST, 10:00-11:15 AM MST, 11:00-12:15 PM CST, 12:00-12:15 PM EST

Location: A Zoom link will be sent in the confirmation email after registration. 

STI Clinical Update Webinar - HCV in 2026: A Clinical Update and Review

January 20, 2026

10:30AM-12:00PM (PST)

1.5 CME units at no cost

Registration closes on January 16, 2026 at 3:00PM (PST)

Presenters

Norah Terrault, MD, MPH, FAASLD

Professor of Medicine

Chief, Division of Gastrointestinal and Liver Diseases

Neil Kaplowitz Chair in Liver Diseases

Keck School of Medicine of USC

University of Southern California

Kurtis Mohr, MD, AAHIVM

Public Health Medical Officer, Office of STIs and HCV

California Department of Public Health

Course Description

• Co-sponsored by the California Department of Public Health and California Prevention Training Center at the University of California San Francisco, this STI Clinical Update webinar will provide a comprehensive review of hepatitis C (HCV) in 2026, focusing on clinical cases and test-to-treat models of care. 

Learning Objectives

• Understand and apply the test-to-treat model for hepatitis C
  Participants will learn how to initiate direct-acting antiviral (DAA) therapy at the point of diagnosis, including in community settings, using Dr. Terrault, AASLD or CDPH, or other simplified treatment pathways. Literature supporting the effectiveness and feasibility of test-to-treat will be reviewed.

• Use case-based scenarios to identify key clinical considerations
  Through interactive case studies, providers will explore how to interpret relevant lab values, assess comorbidities, and evaluate potential drug interactions when initiating DAA therapy. Emphasis will be placed on practical decision-making using simplified treatment algorithms.

• Implement appropriate monitoring and follow-up during hepatitis C treatment
  Attendees will learn recommended baseline and follow-up laboratory testing, including HCV RNA viral load timing, and understand whether there is a need for and the frequency and purpose of clinical follow-up visits throughout the treatment course.

Registration Confirmation Email with Zoom Webinar Link

• Within 24 hours of registering for the webinar, you will receive an email confirmation of your registration from training@nnptc.org sent to the email address you used to register with for the webinar on NNPTC.
• Please note: Zoom webinar link is included in your NNPTC registration confirmation email. 
• Please review the registration confirmation email and complete the Zoom webinar instructions.
• Please do not share or forward any links associated with the webinar.
• Those not registered on NNPTC who sign on to the webinar will not be counted in attendance or eligible to receive CME credit.
• To ensure you receive the NNPTC registration confirmation email, please add training@nnptc.org to your safe/trusted senders list and be sure to monitor both your inbox and spam/junk folders for the notification.

ACCME Disclosure

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nevada, Reno School of Medicine and California Prevention Training Center. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians. The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement. Nurses should check with their individual licensing boards to confirm the acceptability of AMA credits for the purpose of licensing renewal.

Financial Disclosure

As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of a continuing medical education activity disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.

3 Day Rural STI Intensive Course

OBJECTIVES 

1.  Identify the conditions most commonly seen included in the differential diagnosis of STIs

2.  Discuss the diagnosis, management, treatment and prevention of HIV

3.  Discuss methods for managing a patient presenting to a clinical setting infected with or at risk for an STI

4.  Describe the role of the disease intervention specialist (DIS) in STI control

5.  Discuss impacts of rural health settings on STI management

CME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Alabama Marnix E. Heersink School of Medicine and the STD/HIV Prevention Training Center at Johns Hopkins. The University of Alabama Heersink School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Alabama Heersink School of Medicine designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dr. Andrea Cox would like to disclose that their institution gets money from NIH and they get a consulting fee from Eradivir, Inc.  Dr. Ghanem would like to disclose that they get royalties from UpToDate.  Dr. Pinto wishes to disclose that their institution gets money from Hologic and Roche,and they get their travel covered by Hologic.  

All other speakers do not have anything to disclose

There is no commercial support for this activity. 

CNE

This nursing continuing Professional Development activity was approved by the Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

There are 15.25 nursing contact hours awarded for those who attend the entire program as well as complete the evaluation for this program.

Dr. Andrea Cox would like to disclose that their institution gets money from NIH and they get a consulting fee from Eradivir, Inc.  Dr. Ghanem would like to disclose that they get royalties from UpToDate.  Dr. Pinto wishes to disclose that their institution gets money from Hologic and Roche, and they get their travel covered by Hologic.  

None of the planners for this activity have relevant financial relationship(s) with ineligible companies to disclose.

*This Course will take place on February 12, 2026 from 9AM - 12 PM CST

STI Update: Sex throughout the Generations

Target Audience:  Physicians, midlevel practitioners (PA, NP), nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs).

Course Description: Faculty and staff from the St. Louis STI/HIV Prevention Training Center will discuss the realities of providing sexual healthcare throughout the lifetime, starting at youth to our older patients. Including but not limited to: case discussion, treatment options, & innovative ideas on sexual healthcare.

Our Sexual Health Series is a monthly virtual classroom designed to help health workers and clinicians deepen their knowledge of sexual health. Sessions feature content experts who provide advanced education, highlight model programs, and share best practices. It’s essentially an advanced sex education series for professionals.

The January session will provide an overview of injectable options and recent advances, highlighting successful HIV injectable programs from the South with a focus on implementation, benefits navigation, and shared decision-making.This interactive community was established to connect providers across neighboring Southeastern states, fostering the exchange of best practices and collaborative problem-solving in the field of sexual and reproductive health.

Injectable Prep: Injectables in the South

February 18, 2026 | 10:30 AM Central Time

The Virtual STD Intensive Course content includes review of epidemiology, clinical presentation, diagnosis, treatment, and management for bacterial (gonorrhea, chlamydia, and syphilis) and viral (HPV, HSV) sexually transmitted infections, HIV prevention, vaginitis and PID, and case management discussions.

 Each course is limited to 25-30 participants and is delivered via an interactive online platform over five days.

After completing this registration form, you will be contacted by a member of the Denver PTC staff for a brief interview to determine course eligibility. You will then be given an access code to complete the registration process. You are not registered for this course unless you have received a confirmation that the registration process is complete.

*CE will be provided but is currently pending approval. 

*This course is on March 12 & 13 from 8AM-4:30PM CST both days.

Target Audience:  Physicians, midlevel practitioners (PA, NP), nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs).

Course Description:  This course, an intensive overview of STDs, includes 14 hours of lecture over two days.  Topics presented include gonorrhea, chlamydia, syphilis, trichomoniasis, PID, genital herpes, HPV, hepatitis B, chancroid, urethritis/cervicitis syndromes, pediculosis/ scabies, HIV/AIDS, prevention strategies / PrEP / EPT, and case studies.

Course Objectives:  At the end of this course, participants will be able to:

• Describe clinical features of reportable STDs: syphilis, gonorrhea, chlamydia.
• Understand current STD epidemiological patterns.
• Describe clinical features of common bacterial STDs:  syphilis, gonorrhea, chlamydia
• Recognize clinical presentations of common viral STDs:  genital herpes, HPV
• Demonstrate improved skills in completing STD history and physical exam.
• Discuss clinical characteristics of common vaginal infections:  trichomoniasis, bacterial vaginosis, candidiasis
• Integrate HIV risk assessment into patient care.
• Demonstrate universal precautions during specimen collection.
• Describe current approaches to STD/HIV prevention including pre-exposure prophylaxis and expedited partner therapy.
• Discuss evidence-based strategies for STD treatment, according to CDC’s STD Treatment Guidelines.
  
  

4 Hour Syphilis Update

Objectives

1. 1.Discuss clinical manifestations and management of syphilis and its complications in adults
2. 2.Discuss clinical manifestations and management of syphilis in pregnancy and congenital syphilis
3. 3.Describe recent trends in syphilis epidemiology
4. 4.Understand and interpret serologic test results for syphilis

CME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Alabama Marnix E. Heersink School of Medicine and the STD/HIV Prevention Training Center at Johns Hopkins. The University of Alabama Heersink School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Alabama Heersink School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There is no commercial support for this activity. 

CNE

This nursing continuing Professional Development activity was approved by the Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

There are 4.0 nursing contact hours awarded for those who attend the entire program as well as complete the evaluation for this program.